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                                                ABSTRACT 
Primary Sclerosing Cholangitis:  
Epidemiological Aspects, Prevalence of Elevated IgG4 Levels, and Quality of Life 
 
Maria Benito de Valle, MD 
Department of Internal Medicine and Clinical Nutrition, 
Sahlgrenska Academy, 
University of Gothenburg,  
Gothenburg, Sweden 
 
Background and Aims: Primary sclerosing cholangitis (PSC) is a rare cholestatic disease with 
considerable associated morbidity and mortality. The reported transplant-free survival has ranged 
between 12-18 years. Epidemiological data and information on health related quality of life (HRQL) 
in patients with PSC are scarce and mostly provided from referral centers. Liver transplantation (OLT) 
is the only curative treatment. However, steroid responsiveness has been reported in a subgroup of 
PSC patients with elevated serum IgG4 values. The aim of this thesis was to investigate the incidence 
and prevalence of PSC and the risk of malignancy and OLT or death in patients with PSC in a 
population-based setting in Västra Götaland, Sweden. We also aimed to assess HRQL and the 
prevalence of elevated serum IgG4 in patients with PSC in the Västra Götaland PSC cohort merged 
with an English and a German PSC cohort respectively. 
Results: The incidence rate of PSC diagnosed during the study period in Västra Götaland Sweden was 
1.22 per 100 000 person-years. The incidence of PSC increased by 3% per year (95% confidence 
interval (CI) 0.01 to 6.20). Thirty- four out of 345 (10%) patients with PSC had elevated serum IgG4 
values. A previous history of pancreatitis, intra- and extrahepatic biliary involvement and jaundice 
were associated with elevated IgG4 in multivariate analysis. Mortality in PSC patients was four times 
higher (Standardized Mortality Ratio (SMR) 4.20; 95% CI 3.01-5.69) compared with the background 
population in Västra Götaland. Standardized incidence ratio (SIR) for cholangiocarcinoma (CCA) was 
868 (95% CI 505-1390), whereas the SIR for colorectal cancer was not significantly increased 
compared with the general population. Age, female gender, jaundice, cholangitis and bilirubin were 
associated with an increased risk of liver-related death or OLT, whereas high age was a risk factor for 
CCA. Elevated serum IgG4 values was not a risk factor for death or OLT (relative risk (RR) = 0.59, 
95% CI (0.28-1.22) or CCA (RR= 0.45, 95% CI (0.06-3.35). Patients with PSC had significantly lower 
scores from several areas of the short-form 36 (SF-36), compared with controls. Age (β=-0.62 to -0.21, 
p<0.05) and systemic symptoms (β=3.84-15.94, p<0.05) such as pruritus were associated with lower 
scores in physical domains, whereas large duct disease with lower scores in vitality domain of the SF-
36 (β= -7.10, P<0.05). 
Conclusions: The incidence of PSC increased significantly in Västra Götaland during 1992-2005 and 
the observed prevalence is the highest reported to date. The prevalence of elevated serum IgG4 was 
similar to that reported in previous studies. The SMR and SIR for hepatobiliary cancer were similar to 
what has been reported previously in another Swedish study. An unexpected find was that the risk of 
colorectal cancer was not higher than in the background population. In contrast to previous studies, the 
prognosis was similar in patients with elevated and normal serum IgG4 values. HRQL was poorer in 
patients with PSC compared to controls and non life-threatening symptoms such as pruritus were 
associated with impaired HRQL. 
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